title: Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.
abstract: In present study human peripheral blood NK cell activation after co-incubation with K569 cell line was investigated by CD69 expression. NK lytic activity was studied by two different assays: TDA (2,2':6',2″-terpyridine-6,6″-dicarboxylate) release assay (TRA) and flow cytometry assay (FCA) that display two approach to cytotoxicity measurement. We also investigated NK cell degranulation activity by estimation of CD107a (LAMPa) expression. Comparison of specific lysis value measured by both cytotoxicity assays showed high correlation coefficient between two methods (r=0.94447). Specific lysis value correlated significantly with CD69+ NK frequency and NK degranulation activity. We show that lymphocyte incubation with K562 results to increase CD69 expression on NK and NKT but not on T lymphocytes. Only a part of peripheral blood NK cells became CD69 positive after incubation with excess of K562 cells. CD69+ NK cell frequencies did not increase after elevation of K562/NK ratio or incubation period that confirmed existence of subset of NK cells able to response to K562. CD69 elevation on NK significantly correlated with NK cytotoxicity (r=0.726). CD69 increases were similar when whole blood or isolated PBMC was used in assay. We also found different capacity to activation in NK subsets that express CD62L at various densities. The results demonstrated that K562 induced CD69 expression displays NK lymphocyte functional condition that associated with cytotoxic function.
authors.affiliation: Laboratory of Immunology, Institute of Pediatrics, Obstetrics and Gynecology, National Academy of Medical Sciences of Ukraine, Ukraine. boris_donskoy@ukr.net
authors.forename: Boris V
authors.initials: BV
authors.lastname: Dons'koi
authors.forename: Viktor P
authors.initials: VP
authors.lastname: Chernyshov
authors.forename: Darina V
authors.initials: DV
authors.lastname: Osypchuk
mesh_terms: D015703:Antigens, CD / Q000276:immunology*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D015550:Cell Degranulation / Q000276:immunology; D018920:Coculture Techniques / Q000379:methods; D003602:Cytotoxicity, Immunologic / Q000276:immunology; D003998:Dicarboxylic Acids / Q000032:analysis / Q000276:immunology; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology; D020014:K562 Cells; D007694:Killer Cells, Natural / Q000166:cytology / Q000276:immunology*; D037181:Lectins, C-Type / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology; D052118:Lysosomal-Associated Membrane Protein 1 / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D011725:Pyridines / Q000032:analysis / Q000276:immunology; D018709:Statistics, Nonparametric; D015854:Up-Regulation / Q000276:immunology; D000099192:CD69 Antigens
chemical_list: D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D003998:Dicarboxylic Acids; D037181:Lectins, C-Type; D052118:Lysosomal-Associated Membrane Protein 1; D011725:Pyridines; D000099192:CD69 Antigens; C407045:2,2',6',2''-terpyridine-6,6''-dicarboxylic acid